Galectin Therapeutics Inc (GALT) Insider Trading
- $20,803,713.40
- $17,753,147.64
- Oct. 23, 2024
- Kevin D Freeman
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 5, 2019 | Director | 500 | $4.73 | Buy | $2,365.00 | |
Feb. 22, 2019 | Director | 51,185 | $6.02 | Sell | $308,133.70 | |
Feb. 8, 2019 | Director | 1,500 | $4.29 | Buy | $6,435.00 | |
Jan. 31, 2019 | Director | 30,000 | $5.00 | Sell | $150,000.00 | |
Jan. 29, 2019 | Director | 51,500 | $4.87 | Buy | $250,805.00 | |
Sept. 25, 2018 | Director | 2,000 | $6.10 | Buy | $12,200.00 | |
Sept. 10, 2018 | Director | 19,370 | $6.02 | Sell | $116,607.40 | |
Sept. 7, 2018 | Director | 11,000 | $6.03 | Sell | $66,330.00 | |
Sept. 4, 2018 | Director | 11,900 | $6.58 | Sell | $78,302.00 | |
Aug. 30, 2018 | Director | 58,100 | $6.08 | Sell | $353,248.00 | |
June 25, 2018 | Director | 1,000 | $7.06 | Buy | $7,060.00 | |
June 20, 2018 | CFO | 226,000 | $8.61 | Sell | $1,945,860.00 | |
June 18, 2018 | Major Shareholder | 151,860 | $8.61 | Sell | $1,307,514.60 | |
June 18, 2018 | Director | 60,000 | $9.06 | Sell | $543,600.00 | |
June 15, 2018 | Director | 15,475 | $8.47 | Sell | $131,073.25 | |
June 14, 2018 | Major Shareholder | 76,385 | $8.28 | Sell | $632,467.80 | |
June 13, 2018 | Director | 208,140 | $7.17 | Sell | $1,492,363.80 | |
June 13, 2018 | COO | 43,698 | $7.41 | Sell | $323,802.18 | |
June 13, 2018 | CEO | 100,000 | $7.51 | Sell | $751,000.00 | |
June 11, 2018 | CFO | 120,000 | $5.85 | Sell | $702,000.00 | |
June 11, 2018 | COO | 115,054 | $5.84 | Sell | $671,915.36 | |
June 8, 2018 | CEO | 70,000 | $5.86 | Sell | $410,200.00 | |
June 8, 2018 | Director | 110,000 | $5.88 | Sell | $646,800.00 | |
June 8, 2018 | CFO | 100,000 | $5.75 | Sell | $575,000.00 | |
June 7, 2018 | COO | 109,969 | $5.20 | Sell | $571,838.80 | |
June 5, 2018 | COO | 20,831 | $5.15 | Sell | $107,279.65 | |
June 4, 2018 | Major Shareholder | 50,000 | $5.12 | Sell | $256,000.00 | |
June 1, 2018 | COO | 119,200 | $5.06 | Sell | $603,152.00 | |
May 31, 2018 | CFO | 46,651 | $5.00 | Sell | $233,255.00 | |
April 16, 2018 | Director | 4,000 | $3.58 | Sell | $14,320.00 | |
April 4, 2018 | CFO | 3,349 | $5.00 | Sell | $16,745.00 | |
Feb. 1, 2018 | Director | 2,000 | $4.10 | Buy | $8,200.00 | |
Jan. 26, 2018 | Major Shareholder | 244,444 | $5.43 | Sell | $1,327,330.92 | |
Jan. 25, 2018 | Director | 205,144 | $5.45 | Sell | $1,118,034.80 | |
Dec. 8, 2017 | Director | 7,000 | $1.85 | Buy | $12,950.00 | |
May 23, 2017 | Director | 1,000 | $2.27 | Buy | $2,270.00 | |
Jan. 5, 2016 | Director | 1,666 | $1.72 | Buy | $2,865.52 | |
Aug. 12, 2015 | CEO | 2,000 | $2.00 | Buy | $4,000.00 | |
June 1, 2015 | CEO | 4,000 | $2.53 | Buy | $10,120.00 | |
June 1, 2015 | Director | 2,083 | $2.70 | Buy | $5,624.10 | |
Aug. 19, 2014 | Director | 1,000 | $4.56 | Buy | $4,560.00 | |
Aug. 15, 2014 | Director | 1,000 | $4.70 | Buy | $4,700.00 | |
Aug. 14, 2014 | CFO | 1,000 | $4.55 | Buy | $4,550.00 | |
Aug. 14, 2014 | CEO | 4,000 | $4.46 | Buy | $17,840.00 | |
Aug. 13, 2014 | CEO | 1,000 | $4.42 | Buy | $4,420.00 | |
April 11, 2014 | Director | 6,000 | $11.84 | Sell | $71,040.00 | |
Jan. 13, 2014 | Chairman | 100,000 | $14.84 | Sell | $1,484,000.00 | |
Dec. 4, 2013 | Director | 3,000 | $8.69 | Buy | $26,070.00 | |
Nov. 19, 2013 | CEO | 1,000 | $5.53 | Buy | $5,530.00 | |
Nov. 19, 2013 | Director | 2,000 | $6.55 | Buy | $13,100.00 |
Insiders are both buying and selling Galectin Therapeutics Inc stock.
The insider traders at Galectin Therapeutics Inc are: Kevin D Freeman, Fund L.P. 10X, Peter G Traber, Jack W Callicutt, James C Czirr, Kary Eldred, Marc Rubin, Richard A Jr. Zordani, Harold H Shlevin, Joel Lewis, Richard E Uihlein, Arthur Greenberg, Theodore Daniel Zucconi, Gilbert F Amelio, Gilbert S Omenn, John F Mauldin, Steven Prelack, and Elissa J Schwartz
The most active insider trader at Galectin Therapeutics Inc is Kevin D Freeman with 22 trades.
James C Czirr has sold the most Galectin Therapeutics Inc stock with a total value of $5,546,368.61.
Richard E Uihlein has bought the most Galectin Therapeutics Inc stock with a total value of $40,416,566.36.
The most recent insider trade for Galectin Therapeutics Inc was on Oct. 23, 2024.
The single biggest insider buy for Galectin Therapeutics Inc was from Richard E Uihlein with a total value of $20,032,993.68 on May 31, 2019.
The single biggest insider sell for Galectin Therapeutics Inc was from Jack W Callicutt with a total value of $1,945,860.00 on June 20, 2018.